Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares conducted on September 2, 2025. The filing was submitted on September 3, 2025. The Company acted through its corporate stockbroker, Merrill Lynch International, to purchase ordinary shares as part of an existing buyback programme established via a non-discretionary agreement on June 4, 2025.
Key Financial Metrics and Transaction Details
The filing details a specific share repurchase event rather than full-period financial results. Key metrics for the transaction are as follows:
- Shares Purchased: 296,202 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,440.50p; highest price paid was 1,469.00p.
- Average Price: Volume-weighted average price (VWAP) was 1,450.10p.
- Trading Venue: All purchases occurred on the London Stock Exchange (XLON). No purchases were made on CBOE Europe venues (CHIX or BATE).
- Treasury Shares: Following this purchase, the Company holds 244,932,138 ordinary shares in treasury.
- Shares in Issue: 4,070,463,958 ordinary shares (excluding Treasury shares).
- Voting Rights: Treasury shares represent 6.02% of total voting rights.
Material Changes and Programme Progress
Since the commencement of the current buyback agreement on June 4, 2025, the Company has purchased an aggregate of 26,797,755 ordinary shares. The September 2 transaction represents a continuation of this programme. The filing confirms that the purchased shares are held as Treasury shares and do not carry voting rights.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, revenue outlook, or management commentary regarding operational performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in the Company's 2024 Annual Report on Form 20-F and Q2 2025 Results.
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback programme since June 4, 2025 (26,797,755).
- Confirm the current percentage of voting rights held in treasury (6.02%) for disclosure threshold calculations.
- Review the specific transaction prices (1,440.50p to 1,469.00p) against market data for September 2, 2025.
- Note that this filing does not contain revenue, profit, or cash flow data; refer to the Q2 2025 Results for operational metrics.